GO:0061589 calcium activated phosphatidylserine scrambling: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061589 describes the calcium-triggered movement of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane bilayer.
• TMEM16F (ANO6) is the principal calcium-activated phospholipid scramblase responsible for this process in platelets, erythrocytes, and other cell types.
• Loss of TMEM16F function causes Scott syndrome, a bleeding disorder characterized by defective PS exposure and impaired blood coagulation.
• Calcium-activated PS scrambling is a hallmark of eryptosis (programmed erythrocyte death) and contributes to phosphatidylserine exposure during apoptosis-like events.
• TMEM16F-mediated lipid scrambling also regulates extracellular vesicle formation and release, linking this GO term to intercellular communication.
• Emerging evidence implicates TMEM16F scramblase activity in tumorigenesis and modulation of the tumor immune microenvironment.
Description
Calcium activated phosphatidylserine scrambling (GO:0061589) is a biological process defined as the movement of a population of phosphatidylserine molecules from one leaflet of the plasma membrane bilayer to the opposite leaflet as a result of a calcium stimulus. This process is fundamental to the asymmetric organization of eukaryotic plasma membranes, where phosphatidylserine (PS) is normally restricted to the inner (cytoplasmic) leaflet. Upon elevation of intracellular calcium, specialized scramblase proteins catalyze the rapid, bidirectional translocation of PS across the bilayer, exposing it on the cell surface. This exposure serves as a critical signaling event in diverse physiological contexts, including blood coagulation, apoptotic cell clearance, and extracellular vesicle biogenesis. The molecular identity of the calcium-activated scramblase remained elusive for decades until the discovery that TMEM16F (also known as ANO6), a member of the anoctamin family, mediates calcium-dependent phospholipid scrambling. Subsequent structural and functional studies have revealed that TMEM16F forms a membrane protein with a hydrophilic groove that facilitates lipid movement across the bilayer in a calcium-dependent manner. The tether function of anoctamins, including TMEM16F, further underscores their role in maintaining membrane lipid organization and responding to calcium signals. For researchers, GO:0061589 represents a convergence point for studies in hemostasis, cell death, immunology, and cancer biology. Defects in this process are directly linked to bleeding disorders such as Scott syndrome, while dysregulated PS exposure contributes to pathological thrombosis, tumor immune evasion, and impaired clearance of dying cells. Understanding the genes, mechanisms, and regulatory networks underlying calcium-activated PS scrambling is therefore essential for both basic membrane biology and translational medicine.
calcium activated phosphatidylserine scrambling At A Glance
| GO ID | GO:0061589 |
|---|---|
| GO term | calcium activated phosphatidylserine scrambling |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Calcium-dependent translocation of phosphatidylserine across the plasma membrane bilayer |
| Key protein | TMEM16F (ANO6), a calcium-activated phospholipid scramblase |
| Cellular context | Plasma membrane of platelets, erythrocytes, endothelial cells, and other cell types |
| Physiological roles | Blood coagulation, apoptotic cell clearance, extracellular vesicle formation, eryptosis |
| Disease relevance | Scott syndrome, bleeding disorders, cancer immune microenvironment, thrombosis |
What Is GO:0061589?
In our own words, calcium activated phosphatidylserine scrambling (GO:0061589) is the calcium-triggered redistribution of phosphatidylserine lipids from the inner leaflet to the outer leaflet of the plasma membrane. This process disrupts the normal asymmetric lipid arrangement of the membrane and is mediated by calcium-activated scramblase enzymes, most notably TMEM16F. It is a rapid, bidirectional lipid translocation event that does not require ATP and is distinct from flippases and floppases that maintain lipid asymmetry under resting conditions.
Why Is calcium activated phosphatidylserine scrambling Important in Cell Biology?
Calcium activated phosphatidylserine scrambling is critically important because it controls the surface exposure of phosphatidylserine, a lipid that serves as a potent signaling molecule in hemostasis, immune recognition, and cell death. The exposure of PS on activated platelets and injured endothelial cells is essential for the assembly of coagulation factor complexes and fibrin formation. In erythrocytes, PS exposure marks cells for phagocytic clearance and is a hallmark of eryptosis. In cancer, TMEM16F-mediated scrambling can modulate the tumor immune microenvironment, influencing immune evasion and tumor progression. Moreover, the formation and release of extracellular vesicles, which carry bioactive cargo between cells, depends on TMEM16F-mediated lipid scrambling. Thus, understanding GO:0061589 provides mechanistic insight into diverse physiological and pathological processes.
• Essential for blood coagulation: PS exposure on activated platelets provides a surface for tenase and prothrombinase complexes.
• Central to eryptosis: calcium-activated PS scrambling is a hallmark of programmed erythrocyte death.
• Required for extracellular vesicle biogenesis: TMEM16F-mediated scrambling facilitates vesicle formation and release.
• Implicated in Scott syndrome: loss-of-function mutations in TMEM16F cause defective PS exposure and bleeding.
• Modulates tumor immune microenvironment: TMEM16F scramblase activity influences tumorigenesis and immune cell interactions.
• Provides structural insights into lipid scrambling: the closed groove architecture of TMEM16 proteins explains calcium-dependent lipid movement.
• Links calcium signaling to membrane lipid dynamics: anoctamin tether function connects calcium sensors to lipid organization.
• Potential therapeutic target: modulating PS exposure may impact thrombosis, cancer immunotherapy, and inflammatory diseases.
• Guides research on apoptotic cell clearance: PS exposure is an 'eat-me' signal for macrophages.
• Relevant to platelet biology and bleeding disorders: TMEM16F is a major platelet scramblase.
What Happens During calcium activated phosphatidylserine scrambling?
Calcium Influx and Scramblase Activation
In simple terms: When calcium enters the cell, it acts like a key that unlocks the scramblase enzyme.
The process begins with an increase in intracellular calcium concentration, often triggered by cell activation, injury, or apoptotic signals. Calcium binds to the scramblase TMEM16F (ANO6), inducing a conformational change that opens a hydrophilic groove in the protein, allowing lipids to move across the membrane. Structural studies of TMEM16 proteins have revealed that calcium binding to the transmembrane domain is required for the closed groove to transition into a lipid-conducting state. The tether function of anoctamins may also contribute to membrane lipid reorganization during this activation step.
Phosphatidylserine Translocation Across the Bilayer
In simple terms: The scramblase flips phosphatidylserine lipids from the inside of the membrane to the outside.
Once activated, TMEM16F facilitates the bidirectional movement of phosphatidylserine (PS) and other phospholipids between the inner and outer leaflets of the plasma membrane. This scrambling activity is rapid and does not require ATP, distinguishing it from ATP-dependent flippases. The exposed PS on the outer leaflet becomes available for interactions with extracellular proteins, such as coagulation factors and phagocyte receptors. The movement is a population-level event, as defined by GO:0061589, involving many PS molecules rather than a single lipid.
Phosphatidylserine Exposure and Signaling
In simple terms: Once on the outside, phosphatidylserine acts as a signal for blood clotting and cell clearance.
Exposed PS serves as a docking site for coagulation factors, leading to the assembly of the tenase and prothrombinase complexes and subsequent thrombin generation. In erythrocytes, PS exposure is a marker of eryptosis and triggers recognition by macrophages, leading to phagocytic clearance. In the context of extracellular vesicles, PS exposure on the vesicle surface facilitates their formation and release, as well as their uptake by recipient cells. Thus, PS exposure is a versatile signaling event with context-dependent outcomes.
Termination and Membrane Repolarization
In simple terms: After the signal ends, the cell works to restore the normal lipid asymmetry.
Following the cessation of the calcium signal, the scramblase activity diminishes, and ATP-dependent flippases (such as members of the P4-ATPase family) actively transport PS back to the inner leaflet to restore membrane asymmetry. This repolarization is essential for cell survival and prevents inappropriate PS exposure that could lead to pathological thrombosis or immune activation. The balance between scramblase and flippase activities determines the steady-state distribution of PS. In eryptosis, persistent calcium elevation can overwhelm flippase activity, leading to sustained PS exposure and cell death.
Key Genes Involved in GO:0061589 calcium activated phosphatidylserine scrambling
The following genes and proteins are central to calcium activated phosphatidylserine scrambling (GO:0061589), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TMEM16F (ANO6) | Calcium-activated phospholipid scramblase that directly mediates PS translocation | Principal scramblase for GO:0061589; mutations cause Scott syndrome |
| ANO1 (TMEM16A) | Calcium-activated chloride channel with proposed tether function in membrane lipid organization | Anoctamin family member; may modulate membrane lipid dynamics |
| ANO2 (TMEM16B) | Calcium-activated chloride channel; potential auxiliary role in lipid scrambling | Structural and functional studies of anoctamin family |
| ANO3 (TMEM16C) | Anoctamin family member with putative lipid scramblase activity | Less characterized; potential role in calcium-dependent lipid movement |
| ANO4 (TMEM16D) | Anoctamin family member; may contribute to calcium-activated scrambling | Investigated for scramblase activity in heterologous systems |
| ANO5 (TMEM16E) | Anoctamin family member associated with muscle and bone disorders | Potential scramblase activity; disease relevance |
| ANO7 (TMEM16G) | Anoctamin family member expressed in prostate | Possible role in lipid scrambling; understudied |
| ANO8 (TMEM16H) | Anoctamin family member with putative scramblase function | Structural basis of closed groove scrambling |
| ANO9 (TMEM16J) | Anoctamin family member; potential lipid scramblase | Investigated in cancer and inflammation |
| ANO10 (TMEM16K) | Anoctamin family member; calcium-activated scramblase candidate | Linked to spinocerebellar ataxia; lipid scrambling |
| XKR8 | Caspase-activated phospholipid scramblase (distinct from calcium-activated) | Contrasts with TMEM16F in apoptotic PS exposure |
| PLSCR1 | Phospholipid scramblase 1; calcium-binding protein with proposed scramblase activity | Early candidate for PS scrambling; debated role |
| ATP11A | P4-ATPase flippase that maintains PS asymmetry | Counteracts scramblase activity; regulates PS distribution |
| ATP11C | P4-ATPase flippase; transports PS to inner leaflet | Maintains lipid asymmetry in erythrocytes and other cells |
| CDC50A (TMEM30A) | Chaperone subunit for P4-ATPases | Required for flippase function; opposes scrambling |
| TMEM16F (ANO6) in platelets | Mediates PS exposure for coagulation | Target for antithrombotic research |
| TMEM16F (ANO6) in erythrocytes | Mediates PS exposure during eryptosis | Marker of programmed cell death |
| TMEM16F (ANO6) in cancer cells | Modulates tumor immune microenvironment | Potential immunotherapy target |
How Is calcium activated phosphatidylserine scrambling Regulated?
Calcium activated phosphatidylserine scrambling is primarily regulated by intracellular calcium concentration. Calcium binds directly to TMEM16F, inducing conformational changes that open the lipid-conducting groove. The activity is also influenced by membrane lipid composition, particularly the presence of phosphatidylinositol 4,5-bisphosphate (PIP2), which may modulate scramblase function. In erythrocytes, eryptosis is triggered by calcium influx through cation channels, and casein kinase 1α has been implicated in the signaling cascade leading to PS exposure. Additionally, the balance between scramblase and flippase activities determines the extent of PS exposure; ATP11A and ATP11C flippases counteract scrambling by transporting PS back to the inner leaflet. In cancer, the tumor immune microenvironment can influence TMEM16F expression and activity, although the precise regulatory mechanisms remain under investigation.
calcium activated phosphatidylserine scrambling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TMEM16F (ANO6) | Scott syndrome (bleeding disorder) | Patient-derived platelets; TMEM16F knockout megakaryocyte cell line |
| TMEM16F (ANO6) | Eryptosis and anemia | TMEM16F knockout erythroleukemia cells; primary erythrocytes |
| TMEM16F (ANO6) | Cancer immune microenvironment | TMEM16F knockout tumor cell lines; syngeneic mouse models |
| TMEM16F (ANO6) | Thrombosis | Platelet-specific TMEM16F knockout mice; flow chamber assays |
| ATP11A/ATP11C | Membrane asymmetry disorders | Flippase knockout cell lines; PS exposure assays |
Scott Syndrome and Bleeding Disorders
Scott syndrome is a rare inherited bleeding disorder caused by loss-of-function mutations in TMEM16F (ANO6), the principal calcium-activated phospholipid scramblase. Patients with Scott syndrome exhibit defective phosphatidylserine exposure on activated platelets, leading to impaired assembly of coagulation factor complexes and reduced thrombin generation. This results in a mild to moderate bleeding tendency. The discovery of TMEM16F as the defective gene in Scott syndrome provided the first molecular link between calcium-activated PS scrambling and human disease. Research using patient-derived cells and knockout models has been instrumental in elucidating the role of TMEM16F in hemostasis.
Eryptosis and Anemia
Calcium-activated PS scrambling is a hallmark of eryptosis, a form of programmed erythrocyte death. In eryptosis, increased intracellular calcium activates TMEM16F, leading to PS exposure on the erythrocyte surface. This PS exposure triggers phagocytic recognition and clearance of erythrocytes by macrophages, contributing to anemia in conditions such as chronic kidney disease, sepsis, and sickle cell disease. Casein kinase 1α has been identified as a mediator of eryptosis, linking signaling pathways to PS scrambling. Understanding the regulation of PS scrambling in erythrocytes may provide therapeutic targets for anemia and other hematological disorders.
Cancer and Tumor Immune Microenvironment
Emerging evidence implicates TMEM16F-mediated PS scrambling in tumorigenesis and modulation of the tumor immune microenvironment. PS exposure on cancer cells can interact with immune checkpoint receptors, such as TIM-4 and CD300a, to suppress anti-tumor immune responses. TMEM16F expression has been associated with tumor progression in several cancer types, and its scramblase activity may promote extracellular vesicle release, which can influence immune cell recruitment and function. Targeting TMEM16F or PS exposure represents a potential strategy to enhance cancer immunotherapy.
Thrombosis and Cardiovascular Disease
While PS exposure is essential for normal hemostasis, excessive or inappropriate PS scrambling can contribute to pathological thrombosis. In conditions such as atherosclerosis, PS exposure on endothelial cells and macrophages promotes thrombin generation and platelet activation, exacerbating cardiovascular disease. TMEM16F-mediated scrambling in platelets is a key driver of thrombus formation. Modulating this process could offer therapeutic benefits in thrombotic disorders, although careful balance is required to avoid bleeding complications.
From calcium activated phosphatidylserine scrambling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TMEM16F mediate calcium-activated PS scrambling? | TMEM16F knockout HEK293 or HeLa cells; PS exposure assay with annexin V |
| What is the structural basis of calcium-dependent lipid scrambling? | Point mutations in TMEM16F calcium-binding site; cryo-EM and functional assays |
| How does TMEM16F contribute to Scott syndrome? | Patient-derived iPSC-derived megakaryocytes; knock-in of patient mutations |
| What is the role of TMEM16F in extracellular vesicle release? | TMEM16F knockout cells; vesicle isolation and characterization |
| Does TMEM16F modulate tumor immune microenvironment? | TMEM16F knockout tumor cells in syngeneic mouse models; immune profiling |
| How is PS scrambling regulated by flippases? | ATP11A/ATP11C knockout cells; PS asymmetry measurements |
How to Study the calcium activated phosphatidylserine scrambling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | PS exposure on outer leaflet | Quantification of scrambling in platelets and erythrocytes |
| LactC2 biosensor imaging | Real-time PS distribution | Live-cell dynamics of scrambling and repolarization |
| Patch-clamp electrophysiology | Ion channel activity of TMEM16F | Coupling of chloride conductance and lipid scrambling |
| CRISPR knockout screening | Genes regulating PS exposure | Discovery of novel scramblase regulators |
| Cryo-EM structure determination | 3D structure of TMEM16F | Structural basis of calcium-dependent scrambling |
| Extracellular vesicle isolation | Vesicle release and PS content | Role of TMEM16F in vesicle biogenesis |
| Eryptosis assays | PS exposure and cell shrinkage | Study of programmed erythrocyte death |
| Coagulation factor binding | Assembly of tenase/prothrombinase | Functional consequence of PS exposure |
Annexin V Binding Assay
The annexin V binding assay is the gold-standard method to detect phosphatidylserine exposure on the outer leaflet of the plasma membrane. Annexin V is a calcium-dependent protein that binds with high affinity to PS. Cells are stained with fluorescently labeled annexin V and analyzed by flow cytometry or fluorescence microscopy. This method is widely used to study calcium-activated PS scrambling in platelets, erythrocytes, and nucleated cells. It can be combined with calcium ionophores to trigger scrambling and with calcium chelators to confirm calcium dependence.
Live-Cell Imaging with PS Biosensors
Genetically encoded PS biosensors, such as the LactC2 domain fused to fluorescent proteins, allow real-time visualization of PS distribution in living cells. These sensors can be targeted to the inner or outer leaflet to monitor lipid scrambling dynamics. Live-cell imaging provides spatial and temporal resolution of PS exposure following calcium elevation, enabling researchers to track the onset and reversibility of scrambling. This approach is particularly useful for studying the kinetics of TMEM16F activation and the restoration of membrane asymmetry.
Patch-Clamp and Lipid Scrambling Electrophysiology
Electrophysiological techniques, such as patch-clamp recording, can measure the ionic currents associated with TMEM16F activity, although lipid scrambling itself is not electrically charged. However, simultaneous recording of chloride currents and PS exposure can provide insights into the coupling between ion channel and scramblase functions of TMEM16F. These methods are valuable for dissecting the structural determinants of calcium-dependent activation.
CRISPR Screening for Scramblase Regulators
Genome-wide CRISPR knockout screens can identify genes that regulate calcium-activated PS scrambling. Cells are transduced with a CRISPR library, treated with a calcium ionophore, and sorted based on annexin V binding. Enriched or depleted sgRNAs reveal positive and negative regulators of PS exposure. This approach has the potential to uncover novel components of the scrambling machinery and its regulatory network.
How CRISPR Can Be Used to Study GO:0061589 calcium activated phosphatidylserine scrambling
Knockout
CRISPR knockout of TMEM16F (ANO6) is a powerful approach to study calcium-activated PS scrambling. TMEM16F knockout cell lines, such as HEK293 or HeLa, exhibit abolished PS exposure upon calcium ionophore treatment, confirming its essential role. Knockout models can be used to assess the contribution of TMEM16F to platelet activation, extracellular vesicle release, and tumor immune interactions. In erythroleukemia cells, TMEM16F knockout prevents eryptosis-associated PS exposure.
Point Mutation
Point mutations in TMEM16F can dissect the calcium-binding site and the lipid-conducting groove. For example, mutations in the calcium-binding residues abolish scramblase activity, while mutations in the groove may alter lipid selectivity. CRISPR-mediated point mutation knock-in allows the introduction of disease-associated mutations, such as those found in Scott syndrome patients, into cell lines or iPSCs to study the molecular basis of the disorder. These models are valuable for testing pharmacological chaperones or correctors.
Knock-in
Knock-in of tagged TMEM16F (e.g., GFP or HA tag) enables visualization and immunoprecipitation of the scramblase in its native context. Tagged knock-in cell lines can be used for live-cell imaging of TMEM16F trafficking and localization, as well as for proteomic identification of interacting partners. Additionally, knock-in of patient-specific mutations into the endogenous TMEM16F locus provides a physiologically relevant model for Scott syndrome and other disorders.
Overexpression
Overexpression of TMEM16F in heterologous cells, such as HEK293 or CHO cells, is commonly used to study its scramblase activity. Overexpression systems allow researchers to measure calcium-dependent PS exposure using annexin V binding and to test the effects of mutations or inhibitors. Overexpression of TMEM16F can also enhance extracellular vesicle release, providing a model to study the role of lipid scrambling in vesicle biogenesis. However, overexpression may lead to non-physiological effects, so results should be validated in endogenous systems.
How EDITGENE Supports calcium activated phosphatidylserine scrambling Research
Researchers studying calcium activated phosphatidylserine scrambling-related genes often need to determine whether a candidate gene is causally involved in PS exposure, membrane asymmetry, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation of TMEM16F, ANO family members, flippases, and other regulators. By combining knockout, point mutation, knock-in, and overexpression models with library screening and bioinformatics, EDITGENE supports mechanistic studies and therapeutic target validation in this field.
Contact EDITGENE today to design your custom CRISPR model for calcium activated phosphatidylserine scrambling research.
Frequently Asked Questions About calcium activated phosphatidylserine scrambling
What is calcium activated phosphatidylserine scrambling?
Calcium activated phosphatidylserine scrambling (GO:0061589) is the calcium-triggered movement of phosphatidylserine lipids from the inner to the outer leaflet of the plasma membrane, mediated by scramblase enzymes such as TMEM16F.
What genes are involved in calcium activated phosphatidylserine scrambling?
The principal gene is TMEM16F (ANO6), which encodes a calcium-activated phospholipid scramblase. Other anoctamin family members (ANO1-ANO10) and flippases (ATP11A, ATP11C) also play roles in regulating PS distribution.
What is the role of TMEM16F in PS scrambling?
TMEM16F is the main calcium-activated scramblase that directly facilitates the translocation of phosphatidylserine across the plasma membrane upon calcium binding.
How is calcium activated phosphatidylserine scrambling measured?
It is commonly measured using annexin V binding assays, live-cell imaging with PS biosensors, and flow cytometry to detect PS exposure on the outer leaflet.
What diseases are associated with defective PS scrambling?
Defective PS scrambling is linked to Scott syndrome, a bleeding disorder caused by TMEM16F mutations. It is also implicated in anemia, thrombosis, and cancer immune evasion.
What is the difference between scramblase and flippase?
Scramblases facilitate bidirectional lipid movement across the membrane, while flippases (e.g., ATP11A/ATP11C) use ATP to transport PS specifically to the inner leaflet, maintaining membrane asymmetry.
How does calcium activate TMEM16F?
Calcium binds to the transmembrane domain of TMEM16F, inducing a conformational change that opens a hydrophilic groove, allowing lipids to move across the bilayer.
What is the role of PS exposure in blood coagulation?
Exposed PS on activated platelets serves as a docking site for coagulation factors, facilitating the assembly of tenase and prothrombinase complexes and thrombin generation.
Can CRISPR be used to study calcium activated phosphatidylserine scrambling?
Yes, CRISPR knockout, knock-in, and point mutation models of TMEM16F and related genes are widely used to dissect the molecular mechanisms of PS scrambling.
What is eryptosis and how does it relate to PS scrambling?
Eryptosis is programmed erythrocyte death characterized by calcium-activated PS scrambling, leading to PS exposure and phagocytic clearance of erythrocytes.
Conclusion
Calcium activated phosphatidylserine scrambling (GO:0061589) is a fundamental biological process that controls the surface exposure of phosphatidylserine, a lipid critical for blood coagulation, cell death, and immune signaling. The discovery of TMEM16F as the principal calcium-activated scramblase has revolutionized our understanding of membrane lipid dynamics and linked this process to human diseases such as Scott syndrome, anemia, and cancer. Continued research using CRISPR-based models and advanced imaging techniques will further elucidate the regulatory networks and therapeutic potential of targeting PS scrambling. As the field advances, precise genetic tools and bioinformatics approaches will be essential to unravel the complexities of calcium-activated PS scrambling in health and disease. EDITGENE is committed to providing researchers with the highest quality CRISPR services to accelerate discoveries in this important area.
References
- 1. Lin WY et al.. 2024. The tether function of the anoctamins.. Cell Calcium 121:102875 PMID: 38701708
- 2. Feng Z et al.. 2024. Structural basis of closed groove scrambling by a TMEM16 protein.. Nat Struct Mol Biol 31(10):1468-1481 PMID: 38684930
- 3. Wu M et al.. 2025. TMEM16F phospholipid scramblase regulates tumorigenesis by modulating the tumor immune microenvironment.. Proc Natl Acad Sci U S A 122(42):e2513910122 PMID: 41100671
- 4. Suzuki J et al.. 2010. Calcium-dependent phospholipid scrambling by TMEM16F.. Nature 468(7325):834-8 PMID: 21107324
- 5. Lang F et al.. 2006. Mechanisms and significance of eryptosis.. Antioxid Redox Signal 8(7-8):1183-92 PMID: 16910766
- 6. Tkachenko A et al.. 2023. Casein kinase 1α mediates eryptosis: a review.. Apoptosis 28(1-2):1-19 PMID: 36308624
- 7. Le T et al.. 2026. Lipid scrambling via TMEM16F mediates the formation and release of extracellular vesicles.. Mol Biol Cell 37(3):ar22 PMID: 41604453
- 8. Föller M et al.. 2008. Erythrocyte programmed cell death.. IUBMB Life 60(10):661-8 PMID: 18720418
